Comparison of intravesical prostatic protrusion, prostate volume and serum prostatic-specific antigen in the evaluation of bladder outlet obstruction

International Journal of Urology

Volumn 13, Issue 12, 2006, Pages 1509-1513

  Lim, Kok Bin ^a   Ho, Henry ^a   Foo, Keong Tatt ^a   Wong, Michael Yuet Chen ^a   Fook Chong, Stephanie ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Bladder outlet obstruction; Intravesical prostatic protrusion; Prostate specific antigen; Prostatic volume; Ultrasound

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLADDER NECK STENOSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DIGITAL RECTAL EXAMINATION; DISEASE MARKER; ECHOGRAPHY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; ORGAN SIZE; PHYSICAL EXAMINATION; PREDICTION; PRIORITY JOURNAL; PROSTATE FLUID; PROSTATE HYPERTROPHY; RESIDUAL URINE; SCORING SYSTEM; STATISTICAL ANALYSIS; ULTRASOUND SCANNER; UROFLOWMETRY;

AGED; AGED, 80 AND OVER; BIOPSY; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; SEVERITY OF ILLNESS INDEX; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER; URINARY BLADDER NECK OBSTRUCTION; URODYNAMICS;

EID: 33751254385     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2006.01611.x     Document Type: Article

References (22)

1. Chatelain CH, Denis L, Foo KT, Khoury S, McConnell J (eds). 5th International Consultation on BPH. Health United Publications, UK, 2001; 519-33.
2. AUA Practice Guidelines Committee. AUA guideline on management of benign prostatic hyperplasia 2003. Chapter 1: diagnosis and treatment recommendations. J. Urol. 2003; 170: 530-47.
3. Abrams P. Bladder outlet obstruction index, bladder contractility index and bladder voiding efficiency: three simple indices to define bladder voiding function. BJU Int. 1999; 84: 14-15.
4. Klingler HC, Madersbacher S, Djavan B, Schatzl G, Marberger M, Schmidbauer CP. Morbidity of the evaluation of the lower urinary tract with transurethral multichannel pressure flow studies. J. Urol. 1998; 159: 191-4.
5. Onur R, Ozden M, Ornan I, Kalkan A, Semercioz A. Incidence of bacteremia after urodynamic study. J. Hosp. Infect. 2004; 57: 241-4.
6. Marberger MJ, Andersen JT, Nickel JC et al. Prostate volume and serum prostate-specific antigen as predictors of acute urinary retention. Combined experience from three large multinational placebo controlled trials. Eur. Urol. 2000; 38: 563-8.
7. Miyashita H, Kojima M, Miki T. Ultrasonic measurement of bladder weight as a possible predictor of acute urinary retention in men with lower urinary tract symptoms suggestive of benign prostate hyperplasia. Ultrasound Med. Biol. 2002; 28: 985-90.
8. Hakenberg OW, Linne C, Manseck A, Wirth MP. Bladder wall thickness in normal adults and men with mild lower urinary tract symptoms and benign prostate enlargement. Neurourol. Urodyn. 2000; 19: 585-93.
9. Chia SJ, Heng CT, Chan SP, Foo KT. Correlation of intravesical prostatic protrusion with bladder outlet obstruction. BJU Int. 2003; 91: 371-4.
10. Yuen SJ, Ngiap JT, Cheng CW, Foo KT. Effects of bladder volume on transabdominal ultrasound measurements of intravesical prostatic protrusion and volume. Int. J. Urol. 2002; 9: 225-8.
11. Griffths D, Hofner K, van Mastrigt R, Rollema HJ, Spangberg A, Gleason D. Standardization of terminology of lower urinary tract function: pressure-flow studies of voiding, urethral resistance and urethral obstruction. International Continence Society Subcommittee on Standardization of Terminology of Pressure-Flow Studies. Neurourol. Urodyn. 1997; 16: 1-8.
12. Netto NR, D'Ancona CAL, Delima ML. Correlation between International Prostatic Symptom Score and pressure flow study in the evaluation of symptomatic BPH. J. Urol. 1996; 155: 200-2.
13. Wadie BS, Ibrahim EH, de la Rosette JJ, Gomha MA, Ghoneim MA. The relationship of the IPSS and objective parameters for diagnosing bladder outlet obstruction. Part I: when statistics fail. J. Urol. 2001; 165: 32-4.
14. Mochtar CA, Kiemeney LA, van Riemsdijk MM, Laguna MP, Debruyne FM, de la Rosette JJ. Post-void residual urine volume is not a good predictor of the need for invasive therapy among patients with benign prostate hyperplasia. J. Urol. 2006; 175: 213-16.
15. Roehrborn CG, Malice M, Cook TJ, Girman CJ. Clinical predictors of spontaneous acute urinary retention in men with LUTS and clinical BPH: a comprehensive analysis of the pooled placebo groups of several large clinical trials. Urology 2001; 58: 210-16.
16. Anderson JB, Roehrborn CG, Schalken JA, Emberton M. The progression of benign prostatic hyperplasia: examining the evidence and determining the risk. Eur. Urol. 2001; 39: 390-9.
17. Roehrborn CG, Boyle P, Bergner D et al. Serum prostate-specific antigen and prostate volume predict long-term changes in symptoms and flow-rate: results of four-year, randomized trial comparing finasteride versus placebo. PLESS Study Group. Urology 1999; 54: 662-9.
18. Roehrborn CG, Boyle P, Gould AL, Waldstreicher J. Serum prostate specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia. Urology 1999; 53: 581-9.
19. Mochtar CA, Kiemeney LA, van Riemsdijk MM et al. Prostate-specific antigen as an estimator of prostate volume in the management of patients with symptomatic benign prostatic hyperplasia. Eur. Urol. 2003; 44: 695-700.
20. Roehrborn CG, McConnell JD, Lieber M et al. Serum prostate specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. PLESS Study Group. Urology 1999; 53: 473-80.
21. Laniado ME, Ockrim JL, Marronaro A, Tubaro A, Carter SS. Serum PSA to predict the presence of bladder outlet obstruction in men with urinary symptoms. BJU Int. 2004; 94: 1283-6.
22. Tan YH, Foo KT. Intravesical prostatic protrusion predicts the outcome of a trial without catheter following acute urine retention. J. Urol. 2003; 170: 2339-41.